Lung cancer patients screened for genetic clues to future treatments

NCT ID NCT02688894

Recruiting now Knowledge-focused Sponsor: Samsung Medical Center Source: ClinicalTrials.gov ↗

First seen May 04, 2026 · Last updated May 22, 2026 · Updated 3 times

Summary

This study screens up to 797 people with relapsed small cell lung cancer to identify genetic changes in their tumors. No experimental drugs are given; instead, researchers analyze tissue and blood samples to classify cancer subtypes. The goal is to prepare for future trials that match patients to targeted therapies based on their molecular profile.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Chungbuk University Hospital
COMPLETED

Taebuk, South Korea
Gachon University Gil Medical Center
COMPLETED

Incheon, South Korea
Samsung Medical Center
RECRUITING

Seoul, 135-710, South Korea

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Seoul National University Bundang Hospital
COMPLETED

Seongnam, South Korea
Ulsan University Hospital
COMPLETED

Ulsan, South Korea
VHS Medical Center
COMPLETED

Seoul, South Korea

Conditions

Explore the condition pages connected to this study.

NEUROENDOCRINE CARCINOMA SMALL CELL LUNG CANCERS